title: Renal failure in chronic liver disease and the hepatorenal syndrome.
authors: Department of Hepatology, Addenbrooke's Hospital, Cambridge, UK.
authors: Brijesh
authors: B
authors: Srivastava
authors: Graeme J M
authors: GJ
authors: Alexander
mesh_terms: D001663:Bilirubin / Q000097:blood; D002908:Chronic Disease; D055317:Evidence-Based Practice; D005440:Fluid Therapy / Q000379:methods*; D006439:Hemodynamics; D006530:Hepatorenal Syndrome / Q000145:classification / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007668:Kidney / Q000098:blood supply; D008099:Liver / Q000098:blood supply; D008103:Liver Cirrhosis / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D016031:Liver Transplantation; D008236:Lypressin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008991:Monitoring, Physiologic; D018579:Patient Selection; D011170:Portasystemic Shunt, Surgical; D012039:Regional Blood Flow / Q000187:drug effects; D051437:Renal Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D012709:Serum Albumin / Q000032:analysis / Q000378:metabolism; D012720:Severity of Illness Index; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D012709:Serum Albumin; D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin; D001663:Bilirubin